Disease | hepatitis c |
Symptom | C0019189|chronic hepatitis |
Sentences | 24 |
PubMedID- 23639983 | High prevalence of occult hepatitis c virus infection in patients with chronic hepatitis b virus infection. |
PubMedID- 21633525 | Mallory-denk bodies (mdb) are important as investigators, suggesting mdb as an indicator of the histologic severity of chronic hepatitis, causes of which include hepatitis c, primary biliary cirrhosis (pbc), and nonalcoholic fatty liver disease (nafld). |
PubMedID- 23986831 | This 60-year-old man suffered from chronic hepatitis due to hepatitis c virus infection since undergoing a right hepatic lobectomy for hepatocellular carcinoma 5 months earlier. |
PubMedID- 25778685 | Methods: chronic hepatitis patients with genotype 1b hepatitis c virus (hcv) infection showing serum hcv-rna levels greater than 5 log iu/ml received oral administration of cholecalciferol (2000 iu/day) or alfacalcidol (0.5 mug/day) for 4 weeks, and then they were given pegylated interferon (peg-ifn)-alpha2a plus ribavirin therapy in combination with either vitamin d3 for 48 or 72 weeks according to the response-guided manner. |
PubMedID- 22186743 | Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hepatitis c virus. |
PubMedID- 26187292 | However, the enrolled subjects in some studies have also included chronic hepatitis b patients with chronic hepatitis c coinfection or other etiologies of liver diseases. |
PubMedID- 22836284 | Background: chronic hepatitis because of the hepatitis c virus (chc) is a major health problem that can lead to decompensated cirrhosis, hepatocellular carcinoma, and eventually death, all of which are associated with significant healthcare costs. |
PubMedID- 21452540 | hepatitis c leads to chronic hepatitis in 2/3 to 3/4 of cases. |
PubMedID- 24631902 | Prospective evaluation of fibrotest(r), fibrometer(r), and hepascore(r) for staging liver fibrosis in chronic hepatitis b: comparison with hepatitis c. |
PubMedID- 25091289 | Methods: a total of 343 chronic hepatitis patients infected with hepatitis c virus (hcv) genotype 2 (2a: n = 195; 2b: n = 148) were enrolled in this study. |
PubMedID- 22102387 | We classified pathological findings on chronic hepatitis in patients with chronic hepatitis c into minimal, mild, moderate, and severe chronic hepatitis, according to scheuer's scoring system,16 and assessed the effect of occult hbv infection of hepatitis c disease severity. |
PubMedID- 23986848 | This 50-year-old man with chronic hepatitis due to hepatitis c virus infection suffered from recurrent episodes of hepatic encephalopathy since undergoing transcatheter arterial chemoembolization for hepatocellular carcinoma 1 year earlier. |
PubMedID- 25764673 | Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis c virus infection for the fiscal year 2014 in japan. |
PubMedID- 22658873 | Background: the recommended standard therapeutic regimen for chronic hepatitis patients with hepatitis c virus (hcv) genotype 3 is pegylated interferon plus ribavirin for 24 weeks. |
PubMedID- 25755401 | Treatment of chronic hepatitis due to hepatitis c virus (ch-c) in india: a randomized controlled trial comparing daily interferon-alfa-2b and ribavirin with daily interferon-alfa-2b and glycyrrhizin-a multicenter study. |
PubMedID- 23971016 | Alcohol is a strong cofactor for adverse outcomes of hepatitis c; alaska natives with chronic hepatitis c are 17 times more likely to die of liver-related causes than people in the rest of the united states. |
PubMedID- 21677334 | Chronic alcohol abuse (29%) and chronic hepatitis due to hepatitis c virus (hcv) infection (20%) were the most common causes of cirrhosis. |
PubMedID- 24063897 | chronic hepatitis due to the hepatitis c virus (hcv) infection affects nearly 180 million people worldwide. |
PubMedID- 24324359 | A retrospective review of electronic medical records of treatment-naïve hepatitis c patients with chronic hepatitis c confirmed by hcv-rna referred between 2001 and 2009 for hepatitis c management to a single tertiary center was conducted. |
PubMedID- 21979218 | Could trastuzumab suppress hepatitis c virus in a patient with chronic hepatitis and breast cancer. |
PubMedID- 22098550 | Risk factors include chronic hepatitis b (estimated prevalence of 12%), chronic hepatitis c (at least 2% prevalence), and heavy consumption of alcohol among men. |
PubMedID- 22440563 | Many chronic hepatitis patients with hepatitis c virus (hcv) are observed to have a degree of steatosis which is a factor in the progression of liver diseases. |
PubMedID- 21410059 | Non-invasive evaluation of liver fibrosis using acoustic radiation force impulse imaging in chronic hepatitis patients with hepatitis c virus infection. |
PubMedID- 20347177 | Background & aims: progressive deposition of liver fibrosis is a common feature of chronic hepatitis associated with hepatitis c virus (hcv) infection, and it may eventually lead to cirrhosis and liver failure. |
Page: 1